TUDOR INVESTMENT CORP ET AL - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2023$1,353
-99.8%
16,353
+137.5%
0.02%
-40.0%
Q4 2019$791,000
+89.2%
6,886
+108.0%
0.04%
+150.0%
Q3 2019$418,000
-82.8%
3,310
-88.1%
0.01%
-86.0%
Q1 2019$2,426,000
+88.8%
27,729
+115.9%
0.10%
+300.0%
Q4 2018$1,285,000
+69.1%
12,843
+93.5%
0.02%
+31.6%
Q3 2018$760,000
-75.6%
6,637
-80.9%
0.02%
-82.4%
Q2 2018$3,112,000
+161.7%
34,703
+113.6%
0.11%
+176.9%
Q1 2018$1,189,000
+45.9%
16,247
+15.7%
0.04%
+85.7%
Q4 2017$815,000
-19.9%
14,037
-38.1%
0.02%
-19.2%
Q3 2017$1,017,000
-8.5%
22,659
-19.4%
0.03%
-23.5%
Q2 2017$1,111,000
-2.1%
28,126
+0.5%
0.03%
-2.9%
Q1 2017$1,135,000
+130.7%
27,983
+128.5%
0.04%
+169.2%
Q4 2016$492,000
+0.4%
12,246
-27.5%
0.01%
+30.0%
Q2 2016$490,000
+37.6%
16,898
+67.3%
0.01%
-28.6%
Q2 2014$356,000
-63.0%
10,100
-65.8%
0.01%
-65.9%
Q1 2014$962,000
+286.3%
29,518
+400.3%
0.04%
+241.7%
Q4 2013$249,000
-28.2%
5,900
-32.2%
0.01%
-14.3%
Q3 2013$347,000
-14.3%
8,700
-11.2%
0.01%
-53.3%
Q2 2013$405,0009,8000.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders